Pfizer scientist expects elderly, people with underlying conditions to be first to get Covid booster shotsCNBC • 05/04/21
Pfizer brought in $3.5 billion from COVID-19 vaccine sales in the first 3 months of 2021 (PFE)Business Insider • 05/04/21
Pfizer climbs after boosting its 2021 COVID-19 vaccine sales forecast by 73%Business Insider • 05/04/21
Pfizer Beats Q1 Wall Street Estimates; Sees COVID-19 Vaccine Sales Of $26B In FY21Benzinga • 05/04/21
ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIVBusiness Wire • 05/04/21
Pfizer beats earnings expectations and lifts guidance, as COVID-19 revenue outlook increases 73%Market Watch • 05/04/21
Pfizer COVID-19 Vaccine Expected To Get FDA Emergency Approval For Age Group 12-15 Next WeekBenzinga • 05/04/21